89bio Inc (ETNB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

About 89bio Inc

89bio, Inc. (ETNB) is a clinical-stage biopharmaceutical company headquartered in San Francisco, California, specializing in the development of innovative therapies for liver and cardiometabolic diseases. The company focuses on addressing critical unmet medical needs through a promising pipeline of therapies that aim to enhance patient outcomes and overall quality of life. With a strong commitment to research and development, 89bio is strategically positioned to significantly contribute to ad...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for 89bio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ETNB pay dividends?

89bio Inc (ETNB) does not currently pay a regular dividend.